nc medicaid glp 1 coverage KFF's survey of officials found 16 state Medicaid programs covered GLP-1s for obesity treatment as of October 2025. Since then, four states (CA, NH, PA, SC) have ended and North Carolina Medicaid: What to

This compound is supplied strictly for research purposes, and none of this research constitutes clinical evidence of efficacy in human subjects

Candidates who typically benefit most from semaglutide therapy include individuals with obesity (defined medically as a body mass index of 30 or higher) or those who are overweight (with a BMI of 27 or higher) and experiencing weight-related health conditions such as elevated cholesterol, diabetes, or high blood pressure

Prescriptions are written by physicians employed by or contracted with Willow Medical of California, P.C

To determine whether liraglutide treatment affects ER stress in specific islet cell populations, we included probes for 3 ER stress genes in our DART-Seq bead design (Supplemental Table 1)